Huge Underuse of Germline Testing for Cancer Patients

CHICAGO — Fewer than 7% of patients newly diagnosed with cancer are tested for germline genetic mutations, and the percentage tested was even lower among racial and ethnic minorities, a huge study has found. Information from germline genetic testing could affect a patient’s cancer care. For example, such testing could…Read More